SCHEMBL19804584

SCHEMBL19804584

C=C(C)C(=O)OCCc1cc(-c2ccc(-c3ccc4ccccc4c3)c(F)c2)ccc1CCCO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.40
AKR1C2 P52895 3/20 0.40
CCNC P24863 5/20 0.35
CDK8 P49336 5/20 0.35
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
BDKRB1 P46663 2/20 0.32
SUCNR1 Q9BXA5 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
GSTP1 P09211 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19804341 0.92 PTGS1 (0.36) AKR1C3AKR1C2ALOX5APFEN1BDKRB1
SCHEMBL19804049 0.91 PTGS1 (0.37) AKR1C3AKR1C2ALOX5APFEN1CA1
SCHEMBL19624666 0.88 RARB (0.42) AKR1C3AKR1C2RARARARBRARG
SCHEMBL19804449 0.88 PTGS1 (0.36) AKR1C3AKR1C2ALOX5APFEN1CA1
SCHEMBL19804832 0.88 MTNR1A (0.39) CCNCCDK8SLC6A2SLC6A4SLC6A3
SCHEMBL19804120 0.85 CA2 (0.35) AKR1C3AKR1C2CA1CA2RARB
SCHEMBL19804040 0.85 PTGS1 (0.37) AKR1C3AKR1C2ALOX5APFEN1BDKRB1
SCHEMBL19804380 0.85 PTGS1 (0.38) AKR1C3AKR1C2ALOX5APFEN1
SCHEMBL19804378 0.84 PTGS1 (0.36) AKR1C3AKR1C2ALOX5APFEN1BDKRB1
SCHEMBL19007865 0.84 RARB (0.47) RARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 AKR1C3 1789/4885AKR1C2 3097/4885CCNC 609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.